Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01933412
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 100 participants
- Registry
-
NCT01933412
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- Israel
- Registry status
- Unknown status
Technical summary
Registry record NCT01933412. Randomized; no masking; primary purpose prevention. Start 2012-03 (registry gives no type); primary completion 2013-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients
- Condition
- Chronic Kidney Disease
- Condition
- Hepatitis B
- Intervention (Biological)
- Sci-B-Vac Hepatitis B Vaccine
- Intervention (Biological)
- Engerix B Hepatitis B Vaccine
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
Record details
- Record id
cardio:ct-nct01933412- Content hash
6c7d709a73852e894869f960106e7cc70164516e6a63b981fb23f262d78640d6